Case File
efta-01452642DOJ Data Set 10OtherEFTA01452642
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01452642
Pages
1
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
28 January 2014
Brokers. Asset Managers & Exchanges
Alternative Assot Manager Initiation
Rating
Company
Hold
North America
United States
Apollo Global
Management
Research Analyst
Price at 24 Jan 2014
32.20
(USD1
Price Target
31.00
Brokers, Asset
APO N
APO US
52-week range
36.22-20.94-
Managers & Exchanges
11ric,ipitco relairve
Strong performer but solid earnings
peaking out soon; initiate at Hold
Initiating coverage of APO with a Hold Rating and $31 PT
We see APO units trading in a range near current levels over the next 12
months for the following reasons: 1) we see APO as more advanced in its fund
realization cycle than peers, a condition likely to continue into 2014, causing
distributable earnings (DE) to peak in 2013 or 2014 at the latest, 2) despite a
very successful capital raise for Fund VIII at $18bn, DE in 2015-16 is likely to
remain well below 2013-14 levels as Fund VIII remains in a capital deployment
mode through 2016, and distributions from other large funds will likely have
waned, and 3) APO's risk profile is above average with more concentrated
positions, and this could restrain APO's PE expansion in 2014 if the market
becomes choppier vs. 2013. Positively, mgmt is extremely innovative and
several growth initiatives may help buffer the valley in the PE cycle, the
strongest being the Athene/Aviva acquisition, which will enable APO to further
leverage its credit expertise & grow fee earnings. However, we don't think
these efforts will fully offset the DE compression post realization cycle.
Ear nings outlook
We believe DE, from which cash distributions are paid to unit holders, is the
most important earnings metric to value the Alts, rather than economic net
income (ENI) that forms Consensus estimates. We forecast APO's DE per unit
to drop from $3.82 in 2013 to $3.22 in 2014E and $2.70 in 2015E. Key drivers
are: 1) exhausting harvested gains over the next several quarters, 2) Fund VIII
being in investment mode, partially offset by 3) contribution from Aviva.
Valuation & Risk
With positive revaluation for the Alts, we still think APO will expand its P/E
from 10.6x 2014E ENI to over 11-12x 2015E DE 12 months from now,
narrowing its discount to the S&P 500 P/E from -40% to -30%. This drives a
$31 PT, which implies a total return of 6% over the next 12 months, inclusive
of a 9.5% forecast distribution yield for 2014. Downside risks for APO are: 1) a
slowdown in US/global economy, 2) a prolonged equity market correction, 3)
an inability to generate strong growth organically and/or from Aviva in 2014
that would further reduce DE in '15. 4) an inability to deploy capital in Fund
VIII at a reasonable pace & 5) failure to improve PIE vs. traditional asset
managers and the market broadly. Upside risks are: 1) stronger investment
returns than expected that drive much higher DE than forecast, and 2) much
stronger organic growth at Aviva than forecast.
dO
20
20
10
1112
7112
1113
olsodsOlOtolM•00.•
SIP 000 MOCK OlOoodd)
7/I
Performance I%)
1m
3m
12m
Absolute
5.1
-6.3
53.3
S&P 500 INDEX
-2.3
2.2
19.8
Sow* Doistoloi
,•:.7vcat i
Market Cap IUSID)
$12.707
Shares outstanding (ml
393.8-
Free float 1%)
Volume 124 Jan 2014)
229.268-
Option volume lund. slits.. 1M
avg.)
24.047-
Sow* DeastWe
Itripitrxi
I•ini.e.;ri'vo!..:14iPt
12011. -
NOS -
OCOO. ti
len 1 1
OR It
Jon I2 2
en 12
—
duns %Ad
mate: Gamma leg
Deutsche Bank Securities Inc.
Page 33
CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e)
DB-SDNY-0109800
CONFIDENTIAL
SDNY_GM_00255984
EFTA01452642
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.